Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.36% is 85% below its 5-year average of 22.72%, near the low end of its 5-year range (0.83%–73.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 86.60% above its 12-month average of 1.80%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.36%.
DEBT TO ASSETS RATIO
3.36%
DEBT TO ASSETS RATIO AVG TTM
1.80%
DEBT TO ASSETS RATIO AVG 3Y
3.88%
DEBT TO ASSETS RATIO AVG 5Y
22.72%
DEBT TO ASSETS RATIO AVG 10Y
12.49%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+86.60%
CURRENT VS 3Y AVG
-13.45%
CURRENT VS 5Y AVG
-85.22%
CURRENT VS 10Y AVG
-73.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 672 covered companies
CURRENT VS SECTOR MEDIAN
+3257.80%
vs the sector median at left
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$108.30M
Debt to Assets Ratio
3.36%
TTM Avg
1.80%
3Y Avg
3.88%
5Y Avg
22.72%
Market Cap
$107.80M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.07M
Debt to Assets Ratio
0.65%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.16M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.14M
Debt to Assets Ratio
0.70%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.73M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.03M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $108.30M | 3.36% | 1.80% | 3.88% | 22.72% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.80M | 0.07% | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.07M | 0.65% | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $109.16M | 0.14% | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $109.41M | 0.00% | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $110.14M | 0.70% | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.73M | 0.01% | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $111.14M | 0.00% | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.03M | 0.34% | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 0.00% | N/A | N/A | N/A |
Debt/Assets
3.4%
Debt/Equity
0.04
Current Ratio
5.71
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.36% |
| 2026-03-31 | 0.83% |
| 2025-12-31 | 0.97% |
| 2025-09-30 | 1.87% |
| 2025-06-30 | 1.96% |
| 2025-03-31 | 2.04% |
| 2024-12-31 | 2.08% |
| 2024-09-30 | 2.20% |
| 2024-06-30 | 9.74% |
| 2024-03-31 | 13.75% |
| 2023-12-31 | 73.87% |
| 2023-09-30 | 63.00% |
| 2023-06-30 | 54.25% |
| 2023-03-31 | 48.09% |
| 2022-12-31 | 37.84% |
| 2022-09-30 | 34.57% |
| 2022-06-30 | 31.36% |
| 2022-03-31 | 27.35% |
| 2021-12-31 | 24.68% |
| 2021-09-30 | 21.66% |
| 2021-06-30 | 21.63% |
| 2021-03-31 | 18.89% |
| 2020-12-31 | 26.23% |
| 2020-09-30 | 27.32% |
| 2020-06-30 | 8.76% |
| 2020-03-31 | 13.86% |
| 2019-12-31 | 19.22% |
| 2019-09-30 | 12.22% |
| 2019-06-30 | 9.18% |
| 2019-03-31 | 7.46% |
| 2018-12-31 | 0.84% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.12% |
| 2018-03-31 | 0.27% |
| 2017-12-31 | 0.50% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.09% |
| 2017-03-31 | 0.31% |
| 2016-12-31 | 1.55% |
| 2016-09-30 | 0.03% |
| 2016-06-30 | 0.10% |
| 2016-03-31 | 0.89% |
| 2015-12-31 | 1.26% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 1.38% |
| 2014-12-31 | 2.19% |
| 2014-09-30 | 0.99% |
| 2014-06-30 | 7.48% |
| 2014-03-31 | 330.60% |
| 2013-12-31 | 208.85% |
